Literature DB >> 19585269

Experience with the treatment of argininosuccinic aciduria during pregnancy.

L Reid1, E Perreault, G Lafrance, J T R Clarke.   

Abstract

We present the details of the management and the outcome of a pregnancy of a woman affected with argininosuccinic aciduria. Management with a closely monitored, protein-restricted diet, supplemented with L-arginine, resulted in the birth of a healthy infant boy and an uneventful perinatal course for the mother.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19585269     DOI: 10.1007/s10545-009-1145-5

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  6 in total

1.  Successful pregnancy outcome in a woman with argininosuccinate lyase deficiency.

Authors:  M R Mardach; K Roe; S D Cederbaum
Journal:  J Inherit Metab Dis       Date:  1999-04       Impact factor: 4.982

2.  Modifications in the manual on terminology and classification in mental retardation.

Authors:  R HEBER
Journal:  Am J Ment Defic       Date:  1961-01

3.  Pregnancy and argininosuccinic aciduria.

Authors:  S Worthington; J Christodoulou; B Wilcken; B Peat
Journal:  J Inherit Metab Dis       Date:  1996       Impact factor: 4.982

4.  Ornithine transcarbamylase deficiency in pregnancy.

Authors:  D R Cordero; J Baker; D Dorinzi; R Toffle
Journal:  J Inherit Metab Dis       Date:  2005       Impact factor: 4.982

5.  Quebec neonatal mass urinary screening programme: from micromolecules to macromolecules.

Authors:  C Auray-Blais; D Cyr; R Drouin
Journal:  J Inherit Metab Dis       Date:  2007-06-14       Impact factor: 4.982

6.  Newborn urine screening programme in the province of Quebec: an update of 30 years' experience.

Authors:  C Auray-Blais; R Giguère; B Lemieux
Journal:  J Inherit Metab Dis       Date:  2003       Impact factor: 4.982

  6 in total
  1 in total

Review 1.  Impact of pregnancy on inborn errors of metabolism.

Authors:  Gisela Wilcox
Journal:  Rev Endocr Metab Disord       Date:  2018-03       Impact factor: 6.514

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.